This review highlights the unique challenges in managing elderly patients with heart failure, including diastolic dysfunction, polypharmacy, gender disparities, and end-of-life care.
Urges caution applying standard HF therapies to elderly; leaves open targeted trials on diastolic dysfunction, polypharmacy, and disparities.
Heart failure is a leading source of cardiovascular morbidity and mortality in the world. The disease is particlularly prevalent among older patients. The elderly population suffers a high disease burden associated with the distinctive pathophysiology and associated symptoms. There are several challenges healthcare providers face in the management of older patients with heart failure. The present article provides some thoughts on issues in heart failure management in older patients with an emphasis on diastolic heart failure, concerns of polypharmacotherapy, undetected and untreated heart failure among women, and end-of-life care concerns that are relatively unique to an elderly heart failure population. With the expected increase in the number of patients with heart failure and the fact that they might live longer but may suffer more, further efforts are required to aid understanding of the specific needs and challenges for healthier aging, even with a chronic and incurable disease.
No takes yet. Share an insight, caveat, or question.
Dhesi et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: